UNSPSC 85632251: Alteration of left breast with autologous tissue substitute, percutaneous approach

This classification denotes the group of activities that yields a surgical intervention or procedure to alteration of left breast with autologous tissue substitute, percutaneous approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 0H0U37Z

UNSPSC 85632251 "Alteration of left breast with autologous tissue substitute, percutaneous approach" is a Commodity code with no recent state and local procurement activity directly aligned to surgical breast reconstruction procedures. The six most recent state and local contract opportunities posted under or near this code span independent medical evaluation services, surgery benefit carve-out networks, occupational medical surveillance, emergency medical services for detained youth, pharmacy benefit management, and temporary health professional staffing—none of which correspond to the specific surgical procedure the code nominally describes. The mismatch between the code's surgical scope and the actual opportunities posted suggests either erroneous UNSPSC tagging by issuing bodies or that this code does not reflect current state and local buying patterns for the procedure it names.

The recent opportunities cluster around medical administration, occupational health compliance, and network-based benefit management rather than surgical procedures. Issuing bodies include the City of Phoenix Retirement Office (Arizona), City of Long Beach (California), Washington State Department of Transportation, Harris County Juvenile Probation Department (Texas), Collier County Board of County Commissioners (Florida), and County of Santa Clara Health System (California). Geographic spread spans Arizona, California, Texas, Washington, and Florida. Without opportunities directly requesting breast reconstruction or autologous tissue grafting services, this code presents minimal pursuit signal for firms specializing in surgical procedure delivery to state and local entities at this time.